Ouch: Carl Icahn Gets A Dose of His Own Medicine

Agenda-Setting Financial Insight.
Aug. 22 2012 4:59 PM

Ouch: Carl Icahn Gets A Dose of His Own Medicine

What goes around comes around.

Photo by Michael Nagle/Getty Images

Carl Icahn is getting a dose of his own tart medicine. The longtime uppity investor withdrew an offer to buy the remaining 18 percent of $2.6 billion oil refiner CVR Energy after multiple failed attempts to secure full control. That leaves Icahn the majority holder of a public company he can’t take private and couldn’t sell. Now he has to deal with a group that’s in some ways a bit like him: a stubborn minority. 

It isn’t uncommon for the 76-year-old billionaire to abandon acquisition efforts. CVR, in fact, was his first successful takeover after more than a dozen whiffs. In this case, however, despite securing control he’s still walking away for the time being somewhat less than triumphant. Icahn needed 90 percent of CVR’s shares to squeeze out remaining investors and dispense with the annoying and costly requirements of keeping the company listed. 

He doesn’t really seem to want to be an oilman anyway, instead reckoning CVR would be worth more to someone else. He touted the likes of Valero Energy and Tesoro as possible buyers and hired investment bank Jefferies to shop Texas-based CVR for a couple months. Despite reaching out to more than 30 potential suitors, there were no credible offers. 

The dud auction may have had something to do with Icahn’s demands. He wanted at least $35 a share in cash after he won control of CVR with a tender offer at $30. The episode suggests Icahn may be getting too clever for his own good. The CVR bid, like previous efforts to buy Clorox and Lions Gate, was crammed with complex provisions and conditions - in this case contingent value rights for shareholders through next August. 

Accustomed to being in the agitator role, Icahn now gets to see what it’s like on the receiving end. A couple of CVR holdouts already sued him in June, alleging “abuse” because Icahn was buying shares on the open market to get to 90 percent for less than the price he had promised. They asked a court to force CVR’s board to implement a poison pill to prevent Icahn from buying more shares. The case, and the minority shareholders, may be little more than a fatuous nuisance. If anyone would know, it’d be Icahn.

Read more at Reuters Breakingviews

Jeffrey Goldfarb is a New York-based assistant editor with a focus on Wall Street, private equity, M&A and the media industry. Before becoming a columnist, Jeffrey wrote about banking, deals, international trade, healthcare and the Internet.



Blacks Don’t Have a Corporal Punishment Problem

Americans do. But when blacks exhibit the same behaviors as others, it becomes part of a greater black pathology. 

I Bought the Huge iPhone. I’m Already Thinking of Returning It.

Scotland Is Just the Beginning. Expect More Political Earthquakes in Europe.

Students Aren’t Going to College Football Games as Much Anymore

And schools are getting worried.

Two Damn Good, Very Different Movies About Soldiers Returning From War

The XX Factor

Lifetime Didn’t Think the Steubenville Rape Case Was Dramatic Enough

So they added a little self-immolation.

Medical Examiner

The Most Terrifying Thing About Ebola 

The disease threatens humanity by preying on humanity.

Why a Sketch of Chelsea Manning Is Stirring Up Controversy

How Worried Should Poland, the Baltic States, and Georgia Be About a Russian Invasion?

  News & Politics
Sept. 20 2014 11:13 AM -30-
Business Insider
Sept. 20 2014 6:30 AM The Man Making Bill Gates Richer
Sept. 20 2014 7:27 AM How Do Plants Grow Aboard the International Space Station?
  Double X
The XX Factor
Sept. 19 2014 1:11 PM Why Men Never Remember Anything
  Slate Plus
Slate Picks
Sept. 19 2014 12:00 PM What Happened at Slate This Week? The Slatest editor tells us to read well-informed skepticism, media criticism, and more.
Brow Beat
Sept. 20 2014 3:21 PM “The More You Know (About Black People)” Uses Very Funny PSAs to Condemn Black Stereotypes
Future Tense
Sept. 19 2014 5:03 PM White House Chief Information Officer Will Run U.S. Ebola Response
  Health & Science
Bad Astronomy
Sept. 20 2014 7:00 AM The Shaggy Sun
Sports Nut
Sept. 18 2014 11:42 AM Grandmaster Clash One of the most amazing feats in chess history just happened, and no one noticed.